Delivery Order SPE2DB22D1017-SPE2DB25FG7PC
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,528.73 for Linezolid 600 mg tablets (20-count packaging) on September 12, 2025, with completion expected by September 15, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Linezolid is a broad-spectrum antibiotic commonly used in military and federal...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 28, 2025, for 600 mg linezolid tablets in quantities of 20 per unit. This is a firm fixed-price contract with a ceiling value of $5,267.59 and an ultimate completion date of August 29, 2025. The contract was competitively awarded with no set-aside designation. Linezolid is an antibiotic used to treat serious bacterial...
- The Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,809.26 on August 29, 2025, for the supply of Linezolid 600mg in quantities of 20 units. The contract is a firm fixed price delivery order with an ultimate completion date of September 26, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award was not set-aside and was competitively awarded, reflecting AmerisourceBergen's demonstrated...
- The Defense Logistics Agency awarded a $2,660.51 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Linezolid 600 mg tablets in quantities of 20 units. The contract, with an ultimate completion date of September 10, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Linezolid 600 mg tablets in quantities of 20s with a ceiling value of $8,322.43. This firm fixed price delivery order, which carries an ultimate completion date of September 9, 2025, is unset-aside and competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LINEZOLID 600 MG TABLET 20S. The firm-fixed-price contract has a ceiling value of $5,304.04 and an ultimate completion date of August 27, 2024. AmerisourceBergen holds a broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, to provide a comprehensive range of medical...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567060100 LINEZOLID 600 MG TABLET 20S, a prescription medication, with an ultimate completion date of January 28, 2025 and a ceiling value of $4,726.51. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,553.53 firm fixed price delivery order is for the supply of 4568200444 Linezolid 600 mg tablets. The contract has an ultimate completion date of May 12, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...
- This federal contract award, valued at $1,034.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,560,799,928 tablets of the antibiotic Linezolid 600 mg. The contract is a delivery order that runs through May 3, 2023, with a firm fixed price. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,031.18 firm fixed price contract is for the delivery of 4566377190 Linezolid 100 mg/5 ml suspension, a pharmaceutical product used to treat infections. The contract has an ultimate completion date of November 12, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FG7PCDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,350.93 to AmerisourceBergen Drug Corp for the supply of Linezolid 600 mg tablets in quantities of 20s. This competitively awarded, firm fixed price contract was executed on July 17, 2025, with an ultimate completion date of July 18, 2025, and will be performed at the vendor's facility in Conshohocken, Pennsylvania. Linezolid is an antibiotic used to treat serious bacterial infections, including those resistant to other antimicrobial agents, making it a critical pharmaceutical for military and federal healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen Drug Corp serves as a prime vendor supplying a comprehensive range of medications and medical supplies to support military healthcare programs globally. The company's contract portfolio with the DLA demonstrates its capability to fulfill federal procurement requirements across multiple therapeutic domains through competitive procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4k | 7/17/25 |